1954
DOI: 10.1001/archderm.1954.01540190118012
|View full text |Cite
|
Sign up to set email alerts
|

Quinacrine (Atabrine) in Treatment of Solar Dermatoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1958
1958
2003
2003

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 2 publications
0
4
0
Order By: Relevance
“…While chloroquine has shown efficacy in the treatment of PMLE, it has an unacceptable risk for ocular toxicity. The ocular toxicity is believed to come from chloroquine's affinity for melanin (44–47). Since there are other forms of treatment, including other antimalarial drugs, this drug is currently not recommended for use in patients with this disease.…”
Section: Other Therapiesmentioning
confidence: 99%
“…While chloroquine has shown efficacy in the treatment of PMLE, it has an unacceptable risk for ocular toxicity. The ocular toxicity is believed to come from chloroquine's affinity for melanin (44–47). Since there are other forms of treatment, including other antimalarial drugs, this drug is currently not recommended for use in patients with this disease.…”
Section: Other Therapiesmentioning
confidence: 99%
“…Similarly solar urticaria may respond to antimalarials. Woodburn et al (22) and Sams et al (23) have shown that both QE and CQ result in increased sunlight tolerance with improvement in symptoms such as itching and burning.…”
Section: Clinical Studiesmentioning
confidence: 99%
“…Systemically administered 4‐aminoquinolines are bound heavily in the epidermis and absorb UV light in a concentration‐dependent manner (23). Quinacrine has been shown to impede photodynamic actions and can inhibit laser‐induced photosensitivity (22). However, there has been no demonstrable effect of these agents on the minimal erythema dose.…”
Section: Mechanisms Of Actionmentioning
confidence: 99%
“…The antimalarial drugs quinacrine (Atabrine), chloroquine (Aralen), and hydroxychloroquine (Plaquenil) are effective agents for the prevention and treatment of polymorphous light eruption [1][2][3][4][5][6] and also for the treatment of discoid lupus erythematosus. 5,7 A new antimalarial compound, amodiaquin (Camoquin), recently has been reported to be equally valuable in the treatment of discoid lupus erythematosus.8,9…”
mentioning
confidence: 99%